Literature DB >> 3078951

Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.

T Martinsson1, F Ståhl, P Pollwein, A Wenzel, A Levan, M Schwab, G Levan.   

Abstract

Previous studies have shown that cells of the SEWA mouse tumor contain amplified copies of the proto-oncogene c-myc in the aberrant chromosomal structures of double minutes (DMs), homogeneously staining regions (HSRs) and C-bandless chromosomes (CMs). DMs, and to a lesser degree CMs, tend to disappear from the cells grown in vitro and again reappear after transfer back in vivo, as if DNA amplification confers a growth advantage upon the tumor cells. We have now isolated five in vitro clones that exhibit different degrees of c-myc amplification. When we inoculated cells of the different clones into compatible hosts, we found that there was a positive correlation between degree of c-myc amplification, level of c-myc RNA, and tumorigenicity. Our results lend further support to the idea that gene amplification contributes to the higher malignant phenotype, and to progression of tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3078951

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  Deregulated expression of c-Myc in a translocation-negative plasmacytoma on extrachromosomal elements that carry IgH and myc genes.

Authors:  F Wiener; T I Kuschak; S Ohno; S Mai
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Constitutive expression of c-myc oncogene confers hormone independence and enhanced growth-factor responsiveness on cells transformed by human papilloma virus type 16.

Authors:  T Crook; N Almond; A Murray; M Stanley; L Crawford
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone.

Authors:  T Ueda; J H Healey; A G Huvos; M Ladanyi
Journal:  Sarcoma       Date:  1997
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.